Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples.

× No keyword cloud information.

26 in total

1. Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL).

Authors: Paola Secchiero; Elisa Barbarotto; Mario Tiribelli; Carlotta Zerbinati; Maria Grazia di Iasio; Arianna Gonelli; Francesco Cavazzini; Diana Campioni; Renato Fanin; Antonio Cuneo; Giorgio Zauli
Journal: Blood Date: 2006-01-26 Impact factor: 22.113

2. miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities.

Authors: M Mraz; K Malinova; J Kotaskova; S Pavlova; B Tichy; J Malcikova; K Stano Kozubik; J Smardova; Y Brychtova; M Doubek; M Trbusek; J Mayer; S Pospisilova
Journal: Leukemia Date: 2009-01-22 Impact factor: 11.528

3. 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation.

Authors: M K Dijkstra; K van Lom; D Tielemans; F Elstrodt; A W Langerak; M B van 't Veer; M Jongen-Lavrencic
Journal: Leukemia Date: 2008-09-25 Impact factor: 11.528

4. Role of the extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans.

Authors: P Secchiero; D Sun; A L De Vico; R W Crowley; M S Reitz; G Zauli; P Lusso; R C Gallo
Journal: J Virol Date: 1997-06 Impact factor: 5.103

Review 5. MDM2 inhibitors for cancer therapy.

Authors: Lyubomir T Vassilev
Journal: Trends Mol Med Date: 2006-11-28 Impact factor: 11.951

6. Human immunodeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human haematopoietic progenitors (CD34+ cells).

Authors: G Zauli; M C Re; G Furlini; M Giovannini; M La Placa
Journal: J Gen Virol Date: 1992-02 Impact factor: 3.891

7. Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia.

Authors: Kensuke Kojima; Marina Konopleva; Teresa McQueen; Susan O'Brien; William Plunkett; Michael Andreeff
Journal: Blood Date: 2006-03-16 Impact factor: 22.113

8. miR-34a as part of the resistance network in chronic lymphocytic leukemia.

Authors: Thorsten Zenz; Julia Mohr; Eric Eldering; Arnon P Kater; Andreas Bühler; Dirk Kienle; Dirk Winkler; Jan Dürig; Marinus H J van Oers; Daniel Mertens; Hartmut Döhner; Stephan Stilgenbauer
Journal: Blood Date: 2008-10-21 Impact factor: 22.113

9. Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells.

Authors: D Milani; M Mazzoni; P Borgatti; G Zauli; L Cantley; S Capitani
Journal: J Biol Chem Date: 1996-09-20 Impact factor: 5.157

10. Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells.

Authors: Paola Secchiero; Carlotta Zerbinati; Maria Grazia di Iasio; Elisabetta Melloni; Mario Tiribelli; Vittorio Grill; Giorgio Zauli
Journal: Curr Drug Metab Date: 2007-05 Impact factor: 3.731

2 in total

1. SOCS1 is significantly up-regulated in Nutlin-3-treated p53wild-type B chronic lymphocytic leukemia (B-CLL) samples and shows an inverse correlation with miR-155.

Authors: Maria Grazia di Iasio; Alessia Norcio; Elisabetta Melloni; Giorgio Zauli
Journal: Invest New Drugs Date: 2012-01-13 Impact factor: 3.850

2. Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells.

Authors: Veronica Tisato; Alessia Norcio; Claudio Celeghini; Daniela Milani; Arianna Gonelli; Paola Secchiero
Journal: Clinics (Sao Paulo) Date: 2014-01 Impact factor: 2.365

2 in total